Welcome to the english.simm.cas.cn!  
  About Us  
Brief Introduction   History
Address from the Director   Directors
Administration   Contact
  Research Divisions  
National Research Centers
State Key Laboratory of Drug Research
National Center for Drug Screening
National Engineering Laboratory for TCM Standardization Technology
Research Departments
Department of Medicinal Chemistry
Department of Natural Products Chemistry
Department of Pharmacology Ⅰ
Department of Pharmacology Ⅱ
Department of Pharmacology Ⅲ
Drug Discovery and Development Platforms
Drug Efficacy Evaluation Center
Drug Discovery and Design Center
Center for Drug Metabolism and Pharmacokinetics Research
Center for Drug Safety Evaluation and Research
Center for Drug Delivery Research
Research Center for Modernization of Traditional Chinese Medicine
Location: Home > Research Divisions > Research Departments
Update time:
Text Size: A A A

  The department of medicinal chemistry specializes in the research and development of new small molecular chemical entities with independent intellectual property rights (IPRs). It also carries out systematic researches aiming at the basic theories and key techniques that are closely related to the research and development of new drugs. The main research fields include structural optimization of lead compounds, total synthesis of biologically active natural products, combinatorial chemistry, new techniques and methods for drug synthesis and cover antitumor drugs, antibacterials (oxazolidine antimicrobials, fluoroquinolone antimicrobials and carbapenem antimicrobials), antiviral drugs (anti-hepatitis B drugs, anti-HIV drugs), antimalarial agents, antidiabetics, anti-osteoporotic drugs, drugs for diseases of cardiovascular system and nervous system and immunological regulatory system and others. So far, it has developed several new drugs at the leading edge of new drug research in China. In recent years, it has acquired several drug candidates with independent IPRs by means of structural optimization. At present, a series of drug candidates are undergoing preclinical studies.  

CopyRight © Shanghai Institute of Materia Medica,Chinese Academy of Sciences.